Drug Type Toxin |
Synonyms |
Target |
Mechanism Kv1.3 blockers(Voltage-gated potassium channel subunit Kv1.3 blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | MX | 07 May 2012 | |
Immune System Diseases | Discovery | MX | 18 Jun 2019 | |
Immune System Diseases | Discovery | - | 18 Jun 2019 |